Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (71-80 of 418) with videos related to

Pageof 42
Sort By:
Journal of Clinical Microbiology|September 2, 2011
Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based studyGreet De Vlieger, Katrien Lagrou, Johan Maertens, et al.
Acta Clinica Belgica|April 14, 2017
Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in BelgiumJohan Maertens, Carlos Graux, Dimitri Breems, et al.
The Journal of Antimicrobial Chemotherapy|March 14, 2026
Diagnosis and risk factors for invasive mould disease-a round table discussion on directing antifungal therapy according to the available evidenceAna Alastruey-Izqueirdo, Johan Maertens, Monica A Slavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2017
Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic ResponseLaura L Kovanda, Ruwanthi Kolamunnage-Dona, Michael Neely, et al.
Therapeutic Drug Monitoring|November 19, 2016
Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant RecipientsThomas Vanhove, Isabel Spriet, Pieter Annaert, et al.
The Journal of Antimicrobial Chemotherapy|December 24, 2010
Treatment and timing in invasive mould diseaseJohan Maertens, Andreas H Groll, Catherine Cordonnier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2020
Reply to Mafaciolli and PasqualottoPaul E Verweij, Johan Maertens, Sharon C-A Chen, et al.
Infection|February 2, 2024
Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature reviewDorian Vanneste, Matthias Gijsen, Johan Maertens, et al.
British Journal of Haematology|September 9, 2004
Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipientsJohan Maertens, Koen Theunissen, Eric Verbeken, et al.
Journal of Clinical Microbiology|February 5, 2010
Rapid and direct quantification of viable Candida species in whole blood by use of immunomagnetic separation and solid-phase cytometryLies M E Vanhee, Wouter Meersseman, Katrien Lagrou, et al.
Pageof 42

Showing results (71-80 of 418) with videos related to

Sort By:
Pageof 42
Journal of Clinical Microbiology|September 2, 2011
Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based studyGreet De Vlieger, Katrien Lagrou, Johan Maertens, et al.
Acta Clinica Belgica|April 14, 2017
Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in BelgiumJohan Maertens, Carlos Graux, Dimitri Breems, et al.
The Journal of Antimicrobial Chemotherapy|March 14, 2026
Diagnosis and risk factors for invasive mould disease-a round table discussion on directing antifungal therapy according to the available evidenceAna Alastruey-Izqueirdo, Johan Maertens, Monica A Slavin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2017
Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic ResponseLaura L Kovanda, Ruwanthi Kolamunnage-Dona, Michael Neely, et al.
Therapeutic Drug Monitoring|November 19, 2016
Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant RecipientsThomas Vanhove, Isabel Spriet, Pieter Annaert, et al.
The Journal of Antimicrobial Chemotherapy|December 24, 2010
Treatment and timing in invasive mould diseaseJohan Maertens, Andreas H Groll, Catherine Cordonnier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2020
Reply to Mafaciolli and PasqualottoPaul E Verweij, Johan Maertens, Sharon C-A Chen, et al.
Infection|February 2, 2024
Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature reviewDorian Vanneste, Matthias Gijsen, Johan Maertens, et al.
British Journal of Haematology|September 9, 2004
Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipientsJohan Maertens, Koen Theunissen, Eric Verbeken, et al.
Journal of Clinical Microbiology|February 5, 2010
Rapid and direct quantification of viable Candida species in whole blood by use of immunomagnetic separation and solid-phase cytometryLies M E Vanhee, Wouter Meersseman, Katrien Lagrou, et al.
Pageof 42